Janet Dorling Cyma Bay Therapeutics, Inc. (CBAY) insider trading activity

Janet Dorling is of CymaBay Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CBAY, which is worth approximately $0. The most recent transaction as insider was on Feb 12, 2024, when has been sold 6,000 shares (Common Stock) at a price of $31.97 per share, resulting in proceeds of $191,820. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Janet Dorling Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2024	SELL Open market or private sale	$191,820 $31.97 p/Share	6,000 Reduced 100.0%	0 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	$27,780 $4.63 p/Share	6,000 Added 50.0%	6,000 Common Stock
Jan 10 2024	SELL Open market or private sale	$143,160 $23.86 p/Share	6,000 Reduced 100.0%	0 Common Stock
Jan 10 2024	BUY Exercise of conversion of derivative security	$27,780 $4.63 p/Share	6,000 Added 50.0%	6,000 Common Stock
Dec 11 2023	SELL Open market or private sale	$120,420 $20.07 p/Share	6,000 Reduced 100.0%	0 Common Stock
Dec 11 2023	BUY Exercise of conversion of derivative security	$27,780 $4.63 p/Share	6,000 Added 50.0%	6,000 Common Stock
Nov 10 2023	SELL Open market or private sale	$106,680 $15.24 p/Share	7,000 Reduced 100.0%	0 Common Stock
Nov 10 2023	BUY Exercise of conversion of derivative security	$32,410 $4.63 p/Share	7,000 Added 50.0%	7,000 Common Stock

Janet Dorling

Newark, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CBAY shares.

Notify only if

Value

Insider Trading

Get notified when an Cyma Bay Therapeutics, Inc. insider buys or sells CBAY shares.

Notify only if

Operation

Value

Type

News

Receive news related to CymaBay Therapeutics, Inc.

Track Activities on CBAY

Account